Zonsen PepLib Biotech and Novartis Sign Worldwide License Agreement regarding Radioligand Therapy Asset
Empowering the thriving development of peptide therapeutics worldwide, enabling cost‑effective access to peptide medicines for patients around the globe, and contributing to human health.
Hunan Zhongsheng Quanpeptide Biotechnology Co., Ltd.
Contact Information
Email:info@peplib.com
Company Address: Building 5, Modern Service Industry Headquarters Park, No. 1769 Yunlong Avenue, Yunlong Demonstration Zone, Zhuzhou, Hunan Province
Copyright © 2023 Hunan Zhongsheng Quanpeptide Biotechnology Co., Ltd. This website supports IPv6.
Business license